ReGen Biologics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2004
2005
2006
2007
2008
Cash & Short Term Investments
12,190.00
13,279.00
7,916.00
4,108.00
250.00
Total Accounts Receivable
44.00
50.00
83.00
236.00
575.00
Inventories
76.00
368.00
220.00
311.00
400.00
Other Current Assets
236.00
295.00
350.00
336.00
635.00
Total Current Assets
12,546.00
13,992.00
8,569.00
4,991.00
1,860.00
Net Property, Plant & Equipment
55.00
205.00
321.00
402.00
328.00
Total Investments and Advances
-
251.00
-
-
-
Other Assets
123.00
95.00
141.00
109.00
103.00
Total Assets
12,724.00
14,543.00
9,031.00
5,502.00
2,291.00
ST Debt & Current Portion LT Debt
7.00
-
-
-
10,528.00
Accounts Payable
385.00
986.00
447.00
224.00
720.00
Other Current Liabilities
802.00
1,659.00
891.00
431.00
755.00
Total Current Liabilities
1,194.00
2,645.00
1,338.00
655.00
12,003.00
Long-Term Debt
7,140.00
7,425.00
7,780.00
8,187.00
7.00
Other Liabilities
19.00
18.00
57.00
204.00
189.00
Total Liabilities
8,353.00
10,088.00
9,175.00
9,046.00
12,199.00
Common Equity (Total)
7,996.00
6,437.00
11,036.00
12,974.00
13,386.00
Total Shareholders' Equity
4,371.00
4,455.00
144.00
3,544.00
9,908.00
Total Equity
4,371.00
4,455.00
144.00
3,544.00
9,908.00
Liabilities & Shareholders' Equity
12,724.00
14,543.00
9,031.00
5,502.00
2,291.00
Preferred Stock (Carrying Value)
12,367.00
10,892.00
10,892.00
9,430.00
3,478.00
About ReGen Biologics
View Profile
